• 1. Aggregation-induced emission of luminol: a novel strategy for fluorescence ratiometric detection of ALP and As(v) with high sensitivity and selectivity?
  Yuan-Jun Tong,Lu-Dan Yu,Lu-Lu Wu,Shu-Ping Cao,Ru-Ping Liang,Li Zhang,Xing-Hua Xia,Jian-Ding Qiu Chem. Commun., 2018,54, 7487-7490
• 2. An investigation on the interaction modes of a single-strand DNA aptamer and RBP4 protein: a molecular dynamic simulations approach?
  Raheleh Torabi,Hedayatollah Ghourchian,Massoud Amanlou Org. Biomol. Chem., 2016,14, 8141-8153
• 3. An ATP-selective, lanthanide complex luminescent probe?
  Xiao Liu,Jun Xu,Yinyun Lv,Wenyu Wu,Weisheng Liu,Yu Tang Dalton Trans., 2013,42, 9840-9846
• 4. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 5. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789

Professional Introduction to (4-Chloro-pyrazol-1-yl)-acetic acid ethyl ester (CAS No. 51292-40-1)

(4-Chloro-pyrazol-1-yl)-acetic acid ethyl ester is a significant compound in the field of pharmaceutical chemistry, characterized by its unique structural and functional properties. This compound, identified by the Chemical Abstracts Service Number (CAS No.) 51292-40-1, has garnered considerable attention due to its potential applications in drug development and medicinal chemistry. The presence of a chloro substituent on the pyrazole ring and the ester functionality on the acetic acid moiety contribute to its versatile reactivity, making it a valuable intermediate in synthetic chemistry.

The pyrazole core is a heterocyclic aromatic compound that serves as a fundamental scaffold in many biologically active molecules. Its nitrogen-rich structure allows for diverse interactions with biological targets, making it a preferred building block in medicinal chemistry. In particular, the chloro-substituted pyrazole derivative exhibits enhanced reactivity, which can be exploited in various synthetic pathways. This reactivity is particularly useful in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, where the chloro group can be readily displaced by boronic acids or amines, respectively.

The ester functionality of (4-Chloro-pyrazol-1-yl)-acetic acid ethyl ester adds another layer of utility to this compound. Ester groups are commonly employed in pharmaceutical intermediates due to their stability and ease of modification. For instance, hydrolysis of the ester can yield the corresponding carboxylic acid, which can then be further functionalized through various chemical transformations. This adaptability makes it an indispensable tool in the synthesis of more complex molecules.

Recent advancements in drug discovery have highlighted the importance of heterocyclic compounds in developing novel therapeutic agents. Pyrazole derivatives, in particular, have been extensively studied for their antimicrobial, anti-inflammatory, and anticancer properties. The introduction of electron-withdrawing groups such as chlorine enhances the pharmacological activity of these compounds by modulating their electronic properties and improving binding affinity to biological targets. Studies have shown that chlorinated pyrazoles exhibit potent inhibitory effects on enzymes and receptors involved in various diseases.

In the context of oncology research, (4-Chloro-pyrazol-1-yl)-acetic acid ethyl ester has been investigated for its potential as an anticancer agent. Preclinical studies have demonstrated that derivatives of this compound can selectively inhibit the growth of cancer cells by targeting specific molecular pathways. For example, modifications to the pyrazole ring or the acetic acid moiety have led to compounds with improved cytotoxicity and reduced toxicity to healthy cells. These findings underscore the importance of structural optimization in developing effective anticancer therapies.

The compound's role as a synthetic intermediate is further underscored by its utility in producing more complex pharmacophores. By serving as a precursor for various functional groups, it enables chemists to design molecules with tailored properties for specific therapeutic applications. This flexibility is particularly valuable in fragment-based drug design approaches, where small molecular fragments are iteratively modified to improve binding affinity and efficacy.

The synthesis of (4-Chloro-pyrazol-1-yl)-acetic acid ethyl ester typically involves multi-step organic reactions starting from commercially available precursors. The chlorination step is critical and often requires careful control of reaction conditions to ensure high yield and purity. Advances in catalytic systems have made it possible to achieve these transformations under milder conditions, reducing waste and improving sustainability.

From a computational chemistry perspective, understanding the electronic structure and reactivity of this compound is essential for rational drug design. Molecular modeling techniques can predict how different substituents affect the molecule's behavior and interactions with biological targets. These insights can guide experimental efforts by highlighting key structural features that contribute to pharmacological activity.

The growing interest in green chemistry has also influenced the synthesis of (4-Chloro-pyrazol-1-yl)-acetic acid ethyl ester. Researchers are increasingly exploring solvent-free reactions, catalytic methods, and biocatalysis to minimize environmental impact while maintaining high efficiency. Such approaches align with global efforts to develop sustainable chemical processes that reduce reliance on hazardous materials.

In conclusion, (4-Chloro-pyrazol-1-yl)-acetic acid ethyl ester (CAS No. 51292-40-1) is a versatile compound with significant potential in pharmaceutical research and development. Its unique structural features make it a valuable intermediate for synthesizing biologically active molecules, particularly those targeting cancer and inflammatory diseases. As research continues to uncover new applications for this compound, its importance in medicinal chemistry is likely to grow further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)